Nektar Therapeutics
General ticker "NKTR" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $216.1M
Nektar Therapeutics follows the US Stock Market performance with the rate: 35.3%.
Estimated limits based on current volatility of 4.3%: low 0.89$, high 0.97$
Factors to consider:
- US accounted for 12.7% of revenue in the fiscal year ended 2023-12-31
- Current price 28.3% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [1.46$, 3.27$]
- 2023-12-31 to 2024-12-30 estimated range: [1.26$, 2.83$]
Financial Metrics affecting the NKTR estimates:
- Negative: Non-GAAP EPS, $ of -1.90 <= 0.10
- Negative: Operating profit margin, % of -80.34 <= 1.03
- Negative: Operating cash flow per share per price, % of -37.30 <= 2.35
- Negative: negative Net income
Short-term NKTR quotes
Long-term NKTR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $101.91MM | $92.06MM | $90.12MM |
| Operating Expenses | $548.01MM | $468.22MM | $353.81MM |
| Operating Income | $-446.10MM | $-376.17MM | $-263.68MM |
| Non-Operating Income | $-77.18MM | $11.18MM | $-12.57MM |
| Interest Expense | $47.31MM | $28.91MM | $25.33MM |
| R&D Expense | $400.27MM | $218.32MM | $114.16MM |
| Income(Loss) | $-523.28MM | $-364.98MM | $-276.26MM |
| Taxes | $0.56MM | $3.21MM | $-0.20MM |
| Profit(Loss) | $-523.84MM | $-368.20MM | $-276.06MM |
| Stockholders Equity | $679.51MM | $366.64MM | $130.99MM |
| Inventory | $15.80MM | $19.20MM | $16.10MM |
| Assets | $1,117.19MM | $710.60MM | $398.03MM |
| Operating Cash Flow | $-412.66MM | $-304.01MM | $-192.61MM |
| Capital expenditure | $14.99MM | $5.68MM | $0.86MM |
| Investing Cash Flow | $202.78MM | $365.83MM | $139.56MM |
| Financing Cash Flow | $36.24MM | $1.51MM | $0.03MM |
| Earnings Per Share* | $-2.86 | $-1.97 | $-1.45 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.